Another Possible Consequence of the Opioid Epidemic: Hormone Deficiencies
Many people who use opioid medications long term do not produce enough testosterone or another important hormone, cortisol, according to a new study. Full story.
Enhanced Recovery After Spine Surgery: A Systematic Review
Enhanced recovery after surgery (ERAS) is a multidimensional approach to improving the care of surgical patients using subspecialty- and procedure-specific evidence-based protocols. The literature provides evidence of the benefits of ERAS implementation, which include expedited [...]
Robot an Effective Pain Management Tool for Premature Babies
Researchers have designed a therapeutic robot that simulates human skin-to-skin contact, helping reduce pain for babies in the neonatal intensive care unit. Full story.
Association of a Risk Evaluation and Mitigation Strategy Program With Transmucosal Fentanyl Prescribing.
Transmucosal immediate-release fentanyl (TIRF) drugs are potent, rapid-acting opioids approved to treat breakthrough pain in patients with cancer who are tolerant to other around-the-clock opioid analgesics. In March 2012, a US Food and Drug Administration–approved [...]
NIH to Test Experimental Drug to Curb Opioid Cravings
A clinical trial of an experimental drug designed to treat cravings associated with OUD has begun in the National Institutes of Health Clinical Center. The Phase I trial in healthy adults will assess the safety [...]
HHS Releases Additional $487 Million to States, Territories to Expand Access to Effective Opioid Treatment; 2019 SOR Grants Will Total $1.4 Billion
This funding will expand access to treatment that works, especially to medication-assisted treatment (MAT) with appropriate social supports. Full story.
Aegis Science Corporation Presents Corporate Showcase at AAPM35
View the 30-minute webinar: Are drug interactions harming your patients? Enhance DDI identification and patient care with Interact Rx™ Presented by Josh Schrecker, Pharm.D., Clinical Scientist, Healthcare Services, Aegis Science Corporation
Loratadine for Improvement of Bone Pain in Patients with Chronic Granulocyte-Colony Stimulating Factor (G-CSF) Use
G-CSF causes a release of histamine that may be a cause of chronic bone pain. Loratadine targets histamine, and so may be effective in reducing bone pain.The researchers plan to prospectively assess the effectiveness of [...]
PCSS Discussion Forum: A Quick, Evidence-Based Resource from Clinical Experts
The PCSS Discussion Forum provides the opportunity for health professionals to discuss clinical practices around substance use disorders and opioid use disorder with colleagues and addiction and pain experts. (Sign up is required.) Full story.
A Clinical Overview of Off-label Use of Gabapentinoid Drugs
The gabapentinoid drugs gabapentin and pregabalin were originally developed as antiseizure drugs but now are prescribed mainly for treatment of pain. For gabapentin, the only pain-related indication approved by the US Food and Drug Administration [...]